Fertility Preservation in Men: Overview of Current and Emerging Trends

Shah, T.; Giffen, Zane; Fredman, Peter; Gogineni, Vinaya; Sindhwani, Puneet

doi:10.7257/1053-816x.2018.38.5.221

“…While the characteristics of semen specimens produced by transgender women may not be optimal [16], there is evidence that semen samples from individuals seeking gender transition can, nevertheless, be used to initiate conception [17,18]. The sperm abnormalities in these individuals may range from low count, low motility and low normal forms, to azoospermia, in which case fine needle aspiration from the epididymis or the testis may be necessary [19].…”

Section: Sperm Freezingmentioning

confidence: 99%

Fertility Preservation Options for Transgender Patients: An Overview

Mainland,

Dana,

Assaly

et al. 2023

Preprint

0

View full text Add to dashboard Cite

Fertility preservation technologies have existed for decades, and the field is rapidly advancing; limited data exist regarding the use of these technologies by transgender patients. Many options are available for transgender patients who wish to preserve fertility before transitioning. These options include the cryopreservation of gametes, ovarian tissue, or embryos. Currently, ejaculated, or testicular sperm, immature oocytes, and ovarian tissue can be preserved for later use, but no such use option exists for immature testicular tissue. Many financial, sociological, and legal barriers and a lack of awareness among physicians and patients also hindered the utilization of these fertility preservation services. While options are abundant, usage rates are relatively low. The initial data regarding the successful use of preserved tissues appears promising, with birth rates not dissimilar to non-transgender patients. Further investigations into this area are needed. In addition, counseling regarding fertility preservation options should become a significant part of the provider-patient conversation before transitioning therapies.; fertility; transgender; reproductive technology.

show abstract

“…Even individuals not taking hormones may experience difficulty: genital tucking and/or wearing tight undergarments is common among transgender women, and these practices negatively impact sperm quality due to increased heat stress and greater production of reactive oxygen species [20,21]. The sperm abnormalities in these individuals range from low count, low motility, and low normal forms, to azoospermia, in which case fine needle aspiration from the epididymis or the testis may be necessary [22].…”

Section: Sperm Freezingmentioning

confidence: 99%

Fertility Preservation Options for Transgender Patients: An Overview

Mainland,

Ohl,

Assaly

et al. 2023

Uro

Self Cite

0

View full text Add to dashboard Cite

Fertility preservation technologies have existed for decades, and the field is rapidly advancing; limited data exist regarding the use of these technologies by transgender patients. Many options are available for transgender patients who wish to preserve fertility before transitioning. These options include the cryopreservation of gametes, embryos, or ovarian tissue. Currently, ejaculated, or testicular sperm, immature oocytes, and ovarian tissue can be preserved for later use, but no such use option exists for immature testicular tissue. Many financial, sociological, and legal barriers and a lack of awareness among physicians and patients also hinders the utilization of these fertility preservation services. While options are abundant, usage rates are relatively low. The initial data regarding the successful use of preserved tissues appears promising, with birth rates not dissimilar to non-transgender patients. Further investigations into this area are needed. In addition, counseling regarding fertility preservation options should become a significant part of the provider-patient conversation before transitioning therapies.

show abstract

Fertility Preservation Options for Transgender Patients: An Overview

Mainland,

Ohl,

Assaly

et al. 2023

Preprint

0

View full text Add to dashboard Cite

Fertility preservation technologies have existed for decades, and the field is rapidly advancing; limited data exist regarding the use of these technologies by transgender patients. Many options are available for transgender patients who wish to preserve fertility before transitioning. These options include the cryopreservation of gametes, ovarian tissue, or embryos. Currently, ejaculated, or testicular sperm, immature oocytes, and ovarian tissue can be preserved for later use, but no such use option exists for immature testicular tissue. Many financial, sociological, and legal barriers and a lack of awareness among physicians and patients also hindered the utilization of these fertility preservation services. While options are abundant, usage rates are relatively low. The initial data regarding the successful use of preserved tissues appears promising, with birth rates not dissimilar to non-transgender patients. Further investigations into this area are needed. In addition, counseling regarding fertility preservation options should become a significant part of the provider-patient conversation before transitioning therapies.; fertility; transgender; reproductive technology.

show abstract

Fertility Preservation in Men: Overview of Current and Emerging Trends

Cited by 3 publications

References 0 publications

Fertility Preservation Options for Transgender Patients: An Overview

Fertility Preservation Options for Transgender Patients: An Overview

Fertility Preservation Options for Transgender Patients: An Overview

Fertility Preservation Options for Transgender Patients: An Overview

Contact Info

Product

Resources

About